2.9001.69% ( -0.050 )
Delay Closed: Nov 16, 16:08:11Overview
HIGHTIDE-B (2511)
HighTide Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and li...
- Open
- 2.910
- High
- 2.950
- Low
- 2.805
- Prev. Close
- 2.950
- Volume
- 59.00K
- Turnover
- 170.49K
- Avg Price
- 2.890
- Bid/Ask Ratio
- 11.11%
- Amplitude
- 4.92%
- 52wk High
- 4.720
- Volume Ratio
- 0.22
- Turnover Ratio
- 0.01%
- 52wk Low
- 1.800
- HK Mkt Cap
- 1.94B
- Market CapHKD
- 1.94B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.465
- EPSDynamic
- -0.502
- EPSStatic
- --
- BVPS
- 0.29
- P/B
- 10.11
- HK Shares
- 670.04M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 670.04M
- Min lot size
- 500
- Currency
- HKD
HIGHTIDE-B Analyst Rating
View moreForecast & Rating
Jun 19, 2024Price forecast
HK$7.50158.62%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Market Movers · HIGHTIDE-B fell approximately 5%
Market Movers · HIGHTIDE-B fell approximately 6%
Market Movers · Hightide drops 5%
TradingView · HighTide Therapeutics, Inc. Reports Preclinical HTD1801 Data Reducing Cyst Burden in ADPKD Model
Asian Corporate Newswire · ASN 2026: HighTide Therapeutics Presents New HTD1801 Data Highlighting Therapeutic Potential in Chronic Kidney Disease
Global Report · Hong Kong's Forgotten Small Caps Are Splitting in Two
